Loading...
0ACT logo

AlzChem Group AGLSE:0ACT Stock Report

Market Cap €1.3b
Share Price
€127.80
My Fair Value
n/a
1Y119.6%
7D-3.8%
Portfolio Value
View

AlzChem Group AG

LSE:0ACT Stock Report

Market Cap: €1.3b

AlzChem Group (0ACT) Stock Overview

Develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details

0ACT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance6/6
Financial Health6/6
Dividends2/6

0ACT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

AlzChem Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for AlzChem Group
Historical stock prices
Current Share Price€127.80
52 Week High€167.00
52 Week Low€54.18
Beta0.60
1 Month Change-18.70%
3 Month Change-14.00%
1 Year Change119.59%
3 Year Change651.76%
5 Year Change508.57%
Change since IPO522.44%

Recent News & Updates

Recent updates

Shareholder Returns

0ACTGB ChemicalsGB Market
7D-3.8%-2.4%-1.4%
1Y119.6%-9.0%13.8%

Return vs Industry: 0ACT exceeded the UK Chemicals industry which returned -9.1% over the past year.

Return vs Market: 0ACT exceeded the UK Market which returned 13.8% over the past year.

Price Volatility

Is 0ACT's price volatile compared to industry and market?
0ACT volatility
0ACT Average Weekly Movement5.8%
Chemicals Industry Average Movement6.5%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.4%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0ACT has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0ACT's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19081,647Andreas Niedermaierwww.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
0ACT fundamental statistics
Market cap€1.29b
Earnings (TTM)€61.84m
Revenue (TTM)€576.14m
20.8x
P/E Ratio
2.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0ACT income statement (TTM)
Revenue€576.14m
Cost of Revenue€204.84m
Gross Profit€371.30m
Other Expenses€309.46m
Earnings€61.84m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

Feb 26, 2026

Earnings per share (EPS)6.12
Gross Margin64.45%
Net Profit Margin10.73%
Debt/Equity Ratio0%

How did 0ACT perform over the long term?

See historical performance and comparison

Dividends

1.4%
Current Dividend Yield
29%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/24 14:39
End of Day Share Price 2025/11/24 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AlzChem Group AG is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Gerhard OrgonasBerenberg